Patent Assignment
Reel/Frame 065541/0821
Assignment of Assignor's Interest
Recorded: 2023-11-13
Pages: 3
Assignors
BHISE, NUPURA
Executed: 2022-08-31
KATSTRA, JEFFREY
Executed: 2022-09-01
ALTREUTER, DAVID
Executed: 2022-09-01
Assignee
LYNDRA THERAPEUTICS, INC.
65 GROVE STREET, SUITE 301, WATERTOWN, MASSACHUSETTS, 02472
Covered Property
(1)
Gastric Residence Systems Comprising Buprenorphine and Naloxone
Application:
18/289,331 →
Publication:
US 2024/0252483
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License
Jan 11, 2024
From: LYNDRA THERAPEUTICS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066272/0079 →
Assignment of Assignor's Interest
Nov 18, 2025
From: LYNDRA THERAPEUTICS, INC.
To: ISP ACQUISITION COMPANY, INC.
Reel/Frame 073610/0424 →
Change of Name
Nov 19, 2025
From: ISP ACQUISITION COMPANY, INC.
To: NORTIVA BIO, INC.
Reel/Frame 073607/0955 →